Soleil Securities Group lowers its price target on TomoTherapy (Nasdaq: TOMO) from $21 to $10.50 and maintains a Hold ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE